Approval · Notice of Compliance 37417 · 2026
TEVIMBRA: Notice of Compliance 37417
Issued April 16, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 37417
- Date
- April 16, 2026
- Company
- Beone Medicines I GmbhBasel, Switzerland
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TEVIMBRA | Not yet assigned | — |
Medicinal ingredients
- TISLELIZUMAB 100 MG per 10ML